U-50488

From Infogalactic: the planetary knowledge core
(Redirected from U-50,488)
Jump to: navigation, search
U-50488
U-50488.png
Ball-and-stick model of the U-50488 molecule
Systematic (IUPAC) name
2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide
Identifiers
CAS Number 67198-13-4 YesY
PubChem CID: 3036289
IUPHAR/BPS 1652
ChEBI CHEBI:73358 N
ChEMBL CHEMBL441765 N
Chemical data
Formula C19H26Cl2N2O
Molecular mass 369.329 g/mol
 NYesY (what is this?)  (verify)

U-50488 is a drug which acts as a highly selective κ-opioid agonist, but without any μ-opioid antagonist effects.[1] It has analgesic, diuretic and antitussive effects,[2] and reverses the memory impairment produced by anticholinergic drugs.[3] U-50488 was one of the first selective kappa agonists invented and research on its derivatives has led to the development of a large family of related compounds.[4][5]

See also

References

  1. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  2. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  3. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  4. Szmuszkovicz, J (1999). "U-50,488 and the kappa receptor: a personalized account covering the period 1973 to 1990". Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques. 52: 167–95. PMID 10396128.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  5. Szmuszkovicz, J (1999). "U-50,488 and the kappa receptor. Part II: 1991-1998". Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques. 53: 1–51. PMID 10616295.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>